Sarepta Voluntarily Stops Shipments Of Elevidys After Previously Refusing FDA Request

Discussions Ongoing With The Agency

 
• By Mandy Jackson
  
Shipments to non-ambulatory DMD patients already are paused, but now Elevidys will not be shipped to ambulatory boys (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies